Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Response Genetics, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


Exchange/Ticker: Nasdaq: RGDX


Company Description

Response Genetics, Inc. is a life sciences company, which is engaged in the research and development of clinical diagnostic tests for cancer. It has developed technologies for the extraction of RNA from formalin-fixed and paraffin-embedded tissues which enables to reliably recover RNA suitable for a variety of applications, such as gene expression research, development of diagnostics and microarray platforms. The company's platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.

Similar to: ViroPharma, Inc., AstraZeneca Plc, NPS Pharmaceuticals, Inc.

Featured Company


Kindred Healthcare, Inc.

Louisville, KY, US

Kindred Healthcare, Inc., a top-125 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville,… Learn more →

You may also be interested in:


NPS Pharmaceuticals, Inc.

Bedminster, NJ, US

NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →

AstraZeneca Plc

London, LO, GB

AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →

ViroPharma, Inc.

Exton, PA, US

ViroPharma is rare among biotechnology companies. We are in the enviable position of having a strong and growing balance sheet; a… Learn more →